Loading...

EBD Group is part of the Knowledge and Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
NEWS/PRESS RELEASES

BioPharm America offers more high-level opportunities for networking with global life science executives at 2017 edition

BioPharm America offers more high-level opportunities for networking with global life science executives at 2017 edition

 

Carlsbad, CA – July 7, 2017: The tenth annual BioPharm America™ will take place in Boston, MA at the Sheraton Boston Hotel, September 26–27. The event will deliver unequaled value and unparalleled access to global decision makers and innovative biotech startup companies. The event is expected to draw 800+ life science leaders during two impactful days. BioPharm America is now part of Biotech Week Boston, and provides delegates with additional networking opportunities with 4,500+ life science industry influencers participating in 8+ Boston-based events hosted by KNect365 and partners, September 25–28.

 

“BioPharm America is a unique partnering event that enables the most cutting edge biotech companies to break into the inner circle of life science dealmaking,” said Anna Chrisman, Group Managing Director, EBD Group. “There is no other event that captures the energy and excitement of Boston’s startup culture to infuse global partnerships for drug discovery.”

 

Biotech startups have an expanded presence at the event, and will have many opportunities to find best fit partners for every phase of development, from discovery and research, to early clinical development. In addition to company presentations, biotech companies will participate in a Startup Program that includes a Startup Pitch Competition with judges comprised of business development execs, venture capitalists, and industry experts. Top-tier venture capitalists, pharma and private equity investors attend informal networking and evening events in search of innovation partners.

 

Leading pharma executives and investors headlining the program include:

  • Christiana Bardon – Managing Director, Oncology Impact Fund, MPM Capital; Portfolio Manager, Burrage Capital
  • Philip Gotwals, Head, Search and Evaluation Strategic Alliances, Novartis Institutes for BioMedical Research, Inc.
  • Kevin Johnson – Co-Founder and Partner, Medicxi
  • Peter Kolchinsky – Managing Director, RA Capital Management, LLC
  • Nilesh Kumar – Partner, Novo Ventures
  • Lizabeth Leveille – Associate VP and Head, Boston Innovation Hub, BD&L, Merck
  • Eddie Martucci – Co-Founder and CEO at Akili Interactive Labs; VP at PureTech Ventures
  • Rick Pierce – Founder FEP Capital Advisors
  • Chandra Ramanathan – VP and Head, East Coast Innovation Center, Bayer
  • Barbara Russell – Managing Director, Detwiler Fenton
  • Aaron Schwartz – Director, R&D Innovation Sourcing, Novo Nordisk
  • Rafaèle Tordjman – Special Advisor, Sofinnova Partners.

 

BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions, patient advocacy groups, and biotechnology companies of every size and stage, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.

 

Registration information is available on the BioPharm America event web page.

 

 

Additional links and information:

 

Follow BioPharm America™ on Twitter:  @EBDGroup (hashtag: #BioPharmUSA).

 

#

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Innovation Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
  • Cell & Gene Exchange, a partnering forum focused on the patient community in cell and gene therapy sectors, co-produced with Alliance for Regenerative Medicine (ARM).

 

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world. Tune into EBD Group’s Insight for timely coverage of news that influences the business strategies of the life science industry.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.